TSX · BLCO.TO
Bausch + Lomb Corporation
CA$28.49-CA$0.26 (-0.9%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.17% below the high.
Loading market information…
CNQ · AIDR.CN · CAD
Stock price, earnings
Quote as of Oct 30, 2026, 02:45 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Rocket Doctor AI Inc.’s quoted price sits in the lower half of its reported 52-week range, 54.08% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Rocket Doctor AI Inc.’s next earnings report is currently expected on Dec 1, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Rocket Doctor AI Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Rocket Doctor AI Inc., based in Vancouver, Canada, specializes in delivering personalized healthcare information services across the Canadian market. The company develops a mobile application crafted to help users assess their symptoms and effectively manage their health issues, concerns, and ongoing wellness journey. This sophisticated digital health platform also functions as an insightful assessment tool, offering valuable health analytics. Furthermore, Rocket Doctor AI Inc. provides a range of additional solutions, including medical education resources, tools for medical clinics, expert clinical advisory services, and a comprehensive healthcare information hub. Established in 2018, the company was formerly known as Treatment.com AI Inc. and is slated to officially adopt the name Rocket Doctor AI Inc. in August 2025.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:04 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$28.49-CA$0.26 (-0.9%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.17% below the high.
CA$33.48-CA$0.19 (-0.56%)
Apotex Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.67% below the high.
CA$7.69-CA$0.02 (-0.26%)
Vitalhub Corp.’s quoted price sits in the lower half of its reported 52-week range, 30.85% below the high.
CA$6.40CA$0.00 (0.0%)
Custom Health Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.82% below the high.
CA$0.54-CA$0.04 (-6.9%)
NetraMark Holdings Inc’s quoted price sits in the lower half of its reported 52-week range, 58.14% below the high.
CA$0.35-CA$0.01 (-1.43%)
DIAGNOS Inc.’s quoted price sits in the lower half of its reported 52-week range, 34.91% below the high.
CA$0.05+CA$0.01 (+12.5%)
AI/ML Innovations Inc.’s quoted price sits in the lower half of its reported 52-week range, 47.06% below the high.
CA$0.06+CA$0.01 (+20.0%)
Unidoc Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 76.0% below the high.
